Curis, Inc. (CRIS)
0.6811
+0.06
(+9.03%)
USD |
NASDAQ |
Apr 15, 16:00
0.6656
-0.02
(-2.28%)
After-Hours: 20:00
Curis Research and Development Expense (Annual) : 28.25M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agenus, Inc. | 79.34M |
| Plus Therapeutics, Inc. | 8.379M |
| Windtree Therapeutics, Inc. | 16.19M |
| Halozyme Therapeutics, Inc. | 81.49M |
| AIM ImmunoTech, Inc. | 2.786M |